NEW YORK — Fulgent Genetics said on Thursday that it has received a clinical laboratory permit and approval from the New York State Department of Health (NYSDOH) to offer its next-generation sequencing tests.
Fulgent sells genetic tests for a range of diseases and disorders, as well as custom panels for over 18,000 genes. The Temple City, California-based company also offers sequencing services for clinical and research applications.
Fulgent said it has received a NYSDOH molecular genetic testing permit, enabling it to sell its tests and services in New York state.
"The state of New York is a large and untapped market for us, and we look forward to the opportunity to improve patient care with actionable genetic testing solutions for individuals across the state," Fulgent CSO Harry Gao said in a statement.
Earlier this year, Fulgent partnered with the Precision Genomics Laboratory and the department of obstetrics and gynecology at Columbia University Irving Medical Center to offer on-site, expanded carrier screening to patients at the New York City-based academic medical center.